04/13/2016 - 12:17pm

It’s no secret that the category of drugs drawing the most attention — and money — in recent years has been specialty pharmacy.

04/13/2016 - 12:16pm

In February, CEO Update named National Association of Chain Drug Stores president and CEO Steve Anderson Trade Association CEO of the Year. DSN looks at some of the more important work accomplished by NACDS under Anderson’s leadership.

04/13/2016 - 11:00am
CRN has formed a working group to resolve the specifics of the product registry, which is anticipated will contain multiple tiers of product information.
04/13/2016 - 9:52am

The legislation, advocated by both retail pharmacy and the pharma industry, would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.

04/07/2016 - 12:06pm

The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs. 

04/06/2016 - 10:35am

In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.

04/05/2016 - 10:46am

FDA warning letters barring the sale of products containing methylsynephrine  were welcomed by the Council for Responsible Nutrition, which represents dietary supplmement manufacturers and suppliers. 

04/03/2016 - 3:32pm

According to the 2015 National Institute on Drug Abuse’s annual Monitoring the Future survey, one in 30 teens abuses OTC cough medicine containing DXM to get high.

03/31/2016 - 12:54pm

The complaint alleges that Endo paid Impax Laboratories and Watson Laboratories, which were the first companies to file for FDA approval for generics of Endo’s Opana ER and Lidoderm, to delay their generic product launches.